Implant Reduces Treatment Burden in Wet Macular Degeneration

The administration of ranibizumab with an implant, rather than intravitreal injection, looks promising for neovascular age-related macular degeneration, interim results from a phase 3 study indicate.
Medscape Medical News

Full Story →